Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Intracellular Hormone Receptors01:08

Intracellular Hormone Receptors

Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to: Influence of neonatal estrogens on rat prostate development.

Reproduction, fertility, and development·2026
Same author

Polychlorinated biphenyl 153 alters the intestinal epithelial cell transcriptome.

Biomedical reports·2026
Same author

Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry.

Nature communications·2025
Same author

Prostate cancer clinicopathological presentation in South-East Africa during the 2010 decade.

Journal of the National Cancer Institute·2025
Same author

Mesonephric tubules expressing estrogen and androgen receptors remain in the rete ovarii of adult mice.

Cell and tissue research·2024
Same author

Target specification and therapeutic potential of extracellular vesicles for regulating corneal angiogenesis, lymphangiogenesis, and nerve repair.

The ocular surface·2024

Related Experiment Video

Updated: May 31, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Estrogen action and prostate cancer.

Jason L Nelles1, Wen-Yang Hu, Gail S Prins

  • 1Department of Urology, University of Illinois at Chicago, 820 South Wood Street, MC 955, Chicago, IL 60612, USA.

Expert Review of Endocrinology & Metabolism
|July 19, 2011
PubMed
Summary

Estrogens, not just androgens, are increasingly linked to prostate cancer development. This review explores evidence and mechanisms, including epigenetic changes and estrogen receptor roles, in prostate cancer progression.

More Related Videos

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Experiment Videos

Last Updated: May 31, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Historically, androgen deprivation therapy has been the cornerstone of prostate cancer treatment.
  • Emerging research suggests estrogens also play a significant role in prostate cancer etiology and progression.

Purpose of the Study:

  • To review epidemiological, laboratory, and clinical evidence linking estrogens to human prostate cancer.
  • To explore potential mechanisms of estrogen action in prostate cancer.
  • To discuss the roles of different estrogen receptors (ERs) in prostate disease.

Main Methods:

  • Review of epidemiological studies.
  • Analysis of laboratory and clinical evidence.
  • Examination of in vivo models (rodent and grafted).
  • Literature review on molecular mechanisms and estrogen receptor functions.

Main Results:

  • Estrogens are implicated as potential causative agents in prostate cancer development and progression.
  • Mechanisms include epigenetic modifications, genotoxicity, hyperprolactinemia, inflammation, and receptor-mediated actions.
  • Distinct roles for estrogen receptor alpha (ERα), estrogen receptor beta (ERβ), and G-protein-coupled receptor 30 (GPR30) in prostate disease are being elucidated.

Conclusions:

  • Estrogen's role in prostate cancer warrants further investigation.
  • Future research should focus on epigenetic changes, hormonal dysregulation in developing prostate tissue, and specific estrogen receptor signaling pathways.
  • Understanding these pathways may reveal novel therapeutic targets for prostate cancer.